Astragaloside IV Attenuates Chronic Prostatitis by Activating Keap1/Nrf2/HO-1 Pathway: Suppressing Ferroptosis and Enhancing Antioxidant Defense

Press/Media: Research

PeriodJul 28 2025

Media coverage

1

Media coverage